Article info

Download PDFPDF

Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial

Authors

  1. Correspondence to Dr Shunsuke Furuta; shfuruta{at}gmail.com
View Full Text

Citation

Furuta S, Sugiyama T, Umibe T on behalf of the LoVAS Trial study investigators, et al
Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial

Publication history

  • Received July 19, 2017
  • Revised October 2, 2017
  • Accepted October 25, 2017
  • First published December 14, 2017.
Online issue publication 
December 14, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.